暂无数据
快讯 | Hoth Therapeutics Inc - Rocket One 从 Vcu 获得 AI 半导体和自旋电子技术的独家授权
Hoth Therapeutics Intends to Continue Its Biotechnology Programs, Exploring Placing Biotechnology Assets in a Separate, Wholly Owned Subsidiary >HOTH
Press Release: AI Chip Energy Efficiency: Hoth Therapeutics Restructures as Rocket One Inc. to Enter the AI Semiconductor Infrastructure Market With Acquisition of Exclusive Rights to Next Generation AI Semiconductor Acceleration Technology Built on...
Hoth Therapeutics第一季度每股收益(EPS)为$(0.17),较去年同期的$(0.27)有所增长。
Hoth Therapeutics(纳斯达克股票代码:HOTH)报告每股亏损 $(0.17)。这相比去年同一时期每股亏损 $(0.27),增长了 37.04%。
Hoth Therapeutics | 10-Q:季度报表
Hoth Therapeutics 推出了其子公司 Rocket One Space 的倡议。